Hologic Q1 Adj EPS $0.98 Beats $0.95 Estimate, Sales $1.01B Beat $986.12M Estimate
Portfolio Pulse from Benzinga Newsdesk
Hologic, Inc. (NASDAQ:HOLX) reported Q1 adjusted earnings of $0.98 per share, surpassing the consensus estimate of $0.95, a 3.16% beat. However, this represents an 8.41% decrease from last year's earnings of $1.07 per share. The company's quarterly sales reached $1.01 billion, exceeding the consensus estimate of $986.12 million by 2.73%, yet marking a 5.68% decrease from the previous year's $1.07 billion.
February 01, 2024 | 9:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Hologic's Q1 earnings and sales beat estimates but show a year-over-year decline. Adjusted EPS at $0.98 beats $0.95 estimate, and sales of $1.01B exceed $986.12M estimate, yet both figures are down from last year.
While Hologic's Q1 earnings and sales beat analyst expectations, the year-over-year decline in both earnings per share and sales may temper investor enthusiasm. The beat on estimates could provide some short-term positive sentiment, but the decline compared to the previous year's figures introduces caution, leading to a neutral short-term impact assessment.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100